1. Home
  2. BOW vs COLL Comparison

BOW vs COLL Comparison

Compare BOW & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bowhead Specialty Holdings Inc.

BOW

Bowhead Specialty Holdings Inc.

HOLD

Current Price

$22.37

Market Cap

913.3M

Sector

Finance

ML Signal

HOLD

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$34.61

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BOW
COLL
Founded
2020
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
913.3M
1.2B
IPO Year
2024
2015

Fundamental Metrics

Financial Performance
Metric
BOW
COLL
Price
$22.37
$34.61
Analyst Decision
Buy
Strong Buy
Analyst Count
7
6
Target Price
$34.29
$51.17
AVG Volume (30 Days)
218.4K
514.3K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
23.26
N/A
EPS
1.59
1.73
Revenue
$551,589,000.00
$780,567,000.00
Revenue This Year
$21.14
$5.93
Revenue Next Year
$19.15
N/A
P/E Ratio
$13.63
$20.47
Revenue Growth
29.58
23.62
52 Week Low
$21.21
$23.23
52 Week High
$42.29
$50.79

Technical Indicators

Market Signals
Indicator
BOW
COLL
Relative Strength Index (RSI) 40.21 28.83
Support Level $22.15 $34.29
Resistance Level $26.17 $36.20
Average True Range (ATR) 0.82 1.36
MACD -0.13 -0.01
Stochastic Oscillator 29.94 5.72

Price Performance

Historical Comparison
BOW
COLL

About BOW Bowhead Specialty Holdings Inc.

Bowhead Specialty Holdings Inc offers commercial specialty property and casualty insurance products. The company offers underwriting solutions to various businesses across four underwriting divisions, which include Casualty, Professional Liability, Healthcare Liability, and Baleen Specialty. A majority of its revenue is generated from the Casualty division which specializes in general liability coverage, which protects a company against liability arising from bodily injury, personal injury or property damage, for risks in the construction, distribution, heavy manufacturing, real estate, public entity and hospitality segments and also considers underwriting risks in a broader range of industries. Geographically, the company operates in the United States.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.

Share on Social Networks: